May’s top healthcare stories highlight major shifts in drug pricing policies, data-driven health initiatives, and advances in genetic medicine. Public and media attention is focused on government-led cost reforms and growing concerns over transparency and ethics in healthcare research. At the same time, new developments in personalized medicine offer cautious optimism for rare disease treatment. […]
